These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 10482146

  • 1. Comparison of cilostazol versus ticlopidine therapy after stent implantation.
    Park SW, Lee CW, Kim HS, Lee HJ, Park HK, Hong MK, Kim JJ, Park SJ.
    Am J Cardiol; 1999 Sep 01; 84(5):511-4. PubMed ID: 10482146
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of cilostazol versus ticlopidine in coronary artery stenting.
    Yoon Y, Shim WH, Lee DH, Pyun WB, Kim IJ, Jang Y, Cho SY.
    Am J Cardiol; 1999 Dec 15; 84(12):1375-80. PubMed ID: 10606107
    [Abstract] [Full Text] [Related]

  • 3. Effects of cilostazol on angiographic restenosis after coronary stent placement.
    Park SW, Lee CW, Kim HS, Lee NH, Nah DY, Hong MK, Kim JJ, Park SJ.
    Am J Cardiol; 2000 Sep 01; 86(5):499-503. PubMed ID: 11009265
    [Abstract] [Full Text] [Related]

  • 4. RACTS: a prospective randomized antiplatelet trial of cilostazol versus ticlopidine in patients undergoing coronary stenting: long-term clinical and angiographic outcome.
    Ge J, Han Y, Jiang H, Sun B, Chen J, Zhang S, Du Z, RACTS (Randomized Prospective Antiplatelet Trial of Cilostazol Versus Ticlopidine in Patients Undergoing Coronary Stenting) Trial Investigators.
    J Cardiovasc Pharmacol; 2005 Aug 01; 46(2):162-6. PubMed ID: 16044027
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The effects of post coronary stenting triple antiplatelet therapies on platelet functions].
    Han YL, Su QF, Li Y, Kang J, Yan CH, Wang SL.
    Zhonghua Nei Ke Za Zhi; 2006 Aug 01; 45(8):635-8. PubMed ID: 17074146
    [Abstract] [Full Text] [Related]

  • 10. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW, Kang SH, Park JJ, Yang HM, Kang HJ, Koo BK, Park BE, Cha KS, Rhew JY, Jeon HK, Shin ES, Oh JH, Jeong MH, Kim S, Hwang KK, Yoon JH, Lee SY, Park TH, Moon KW, Kwon HM, Chae IH, Kim HS.
    JACC Cardiovasc Interv; 2013 Sep 01; 6(9):932-42. PubMed ID: 24050860
    [Abstract] [Full Text] [Related]

  • 11. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Lee SW, Park SW, Yun SC, Kim YH, Park DW, Kim WJ, Lee JY, Lee CW, Hong MK, Kim JJ, Park SJ.
    Am Heart J; 2010 Feb 01; 159(2):284-291.e1. PubMed ID: 20152228
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
    Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ, DECLARE-LONG II Study Investigators.
    J Am Coll Cardiol; 2011 Mar 15; 57(11):1264-70. PubMed ID: 21392640
    [Abstract] [Full Text] [Related]

  • 16. Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
    Yang TH, Kim DI, Kim DK, Jang JS, Kim U, Seol SH, Kim DK, Hong GR, Park JS, Shin DG, Kim YJ, Cho YK, Nam CW, Hur SH, Kim KB, Kim DS.
    Korean J Intern Med; 2011 Jun 15; 26(2):145-52. PubMed ID: 21716590
    [Abstract] [Full Text] [Related]

  • 17. Randomized Angiographic and Intravascular Ultrasound Comparison of Dual-Antiplatelet Therapy vs Triple-Antiplatelet Therapy to Reduce Neointimal Tissue Proliferation in Diabetic Patients.
    Zuliani Mauro MF, Mangione JA, Costa JR, Costa R, Piva E Mattos LA, Staico R, Feres F, Siqueira D, Sousa A, Abizaid A.
    J Invasive Cardiol; 2017 Mar 15; 29(3):76-81. PubMed ID: 28255102
    [Abstract] [Full Text] [Related]

  • 18. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
    Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Hong MK, Kim HS, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ.
    J Am Coll Cardiol; 2008 Mar 25; 51(12):1181-7. PubMed ID: 18355656
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
    Takeyasu N, Watanabe S, Noguchi Y, Ishikawa K, Fumikura Y, Yamaguchi I.
    Circ J; 2005 Jul 25; 69(7):780-5. PubMed ID: 15988102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.